Skip to main content Accessibility help
  • Print publication year: 2008
  • Online publication date: December 2009

Trigeminal neuralgia

from Chief complaints and diagnoses


Opioids remain the most commonly used, and most commonly recommended, treatment for acute (and acute-on-chronic) pancreatitis. Most of the opioids are acceptable, there are reasons to select the mixed agonist-antagonist buprenorphine. Buprenorphine appears to have advantages related to paucity of effect on Oddi's sphincter. There is conflicting information as to the role of NSAIDs in treating pancreatitis pain. One expert consensus panel included NSAIDs as a first-line treatment for flares of chronic pancreatitis. The cholecystokinin (CCK)-receptor antagonists proglumide and loxiglumide appear to be effective in ameliorating pain from acute exacerbations of pancreatitis. One study demonstrated improvement in both subjective and objective (laboratory) parameters. Given potent inhibitory effects on pancreatic secretion, somatostatin and its analog octreotide have been studied for use in pancreatitis. Prophylactic somatostatin may reduce the rate of pancreatitis after endoscopic retrograde cholangiopancreatography. However, the acute care indications for this drug class are less clear.


1. Wiffen PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev. 2005(3):CD005451.
2. Nicol CF. A four year double-blind study of tegretol in facial pain. Headache. 1969;9(1):54–57.
3. Kaminski HJ, Ruff RL. Treatment of the elderly patient with headache or trigeminal neuralgia. Drugs Aging. 1991;1(1):48–56.
4. McCleane GJ. Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study. Anesth Analg. 1999;89(4):985–988.
5. Wiffen P, Collins S, McQuay H, et al. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2005(3):CD001133.
6. Gatzonis SD, Angelopoulos E, Sarigiannis P, et al. Acute psychosis due to treatment with phenytoin in a nonepileptic patient. Epilepsy Behav. 2003;4(6):771–772.
7. Cheshire WP. Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis. J Pain Symptom Manage. 2001;21(6): 506–510.
8. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, et al. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73(2):223–230.
9. Lunardi G, Leandri M, Albano C, et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology. 1997;48(6):1714–1717.
10. Canavero S, Bonicalzi V. Drug therapy of trigeminal neuralgia. Expert Rev Neurother. 2006;6(3):429–440.
11. Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology. 1998;51(2):611–614.
12. Zvartau-Hind M, Din MU, Gilani A, et al. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology. 28 2000;55(10): 1587–1588.
13. Fromm GH. Baclofen as an adjuvant analgesic. J Pain Symptom Manage. 1994;9(8):500–509.
14. Baker KA, Taylor JW, Lilly GE. Treatment of trigeminal neuralgia: use of baclofen in combination with carbamazepine. Clin Pharm. 1985;4(1):93–96.
15. Idanpaan-Heikkila JJ, Guilbaud G. Pharmacological studies on a rat model of trigeminal neuropathic pain: baclofen, but not carbamazepine, morphine or tricyclic antidepressants, attenuates the allodynia-like behaviour. Pain. 1999;79(2–3):281–290.
16. Fromm GH, Terrence CF. Comparison of l-baclofen and racemic baclofen in trigeminal neuralgia. Neurology. 1987;37(11):1725–1728.
17. Parmar BS, Shah KH, Gandhi IC. Baclofen in trigeminal neuralgia: a clinical trial. Indian J Dent Res. 1989;1(4):109–113.